Showing results (81-90 of 433) with videos related to
Sort By:
Pageof 44
Molecular Imaging and Biology|May 25, 2005
The utility of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in the investigation of patients with disseminated carcinoma of unknown primary originClare L Scott, Iveta Kudaba, Josephine M Stewart, et al.International Journal of Radiation Oncology, Biology, Physics|February 26, 2008
Impact of [18f] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-hodgkin lymphomaAndrew Wirth, Marcus Foo, John F Seymour, et al.Chemical Communications (Cambridge, England)|October 7, 2016
A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodiesStacey E Rudd, Peter Roselt, Carleen Cullinane, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2018
A First-in-Human Study of <sup>68</sup>Ga-Nanocolloid PET/CT Sentinel Lymph Node Imaging in Prostate Cancer Demonstrates Aberrant Lymphatic Drainage PathwaysJacki A Doughton, Michael S Hofman, Peter Eu, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 9, 2017
The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and ImmunotherapyAnnie N M Wong, Grant A McArthur, Michael S Hofman, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2006
Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgeryVictor Kalff, Cuong Duong, Elizabeth G Drummond, et al.Gynecologic Oncology|April 22, 2006
The impact of PET/CT in the management of recurrent ovarian cancerBryony Simcock, Deborah Neesham, Michael Quinn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2006
Powerful prognostic stratification by [18F]fluorodeoxyglucose positron emission tomography in patients with metastatic breast cancer treated with high-dose chemotherapyFlorent Cachin, H Miles Prince, Annette Hogg, et al.Cancer Biotherapy & Radiopharmaceuticals|November 3, 2009
High-administered activity In-111 octreotide therapy with concomitant radiosensitizing 5FU chemotherapy for treatment of neuroendocrine tumors: preliminary experienceGrace Kong, Val Johnston, Shakher Ramdave, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 13, 2015
The role of positron emission tomography/computed tomography in planning radiotherapy in endometrial cancerBryony Simcock, Kailash Narayan, Elizabeth Drummond, et al.Pageof 44